Dr. Stuart Turvey, MBBS, DPhil, FRCPC is an associate professor of pediatrics at the University of British Columbia where he holds the Aubrey J. Tingle Professorship in Pediatric Immunology. He is a pediatric immunologist based at BC Children’s Hospital, and director of clinical research at the Child & Family Research Institute. Prior to coming to Vancouver, Turvey completed both his pediatric residency and allergy/immunology fellowship at Children’s Hospital, Harvard Medical School, Boston. He holds a medical degree (MB BS) from the University of Sydney, Australia and a doctorate (DPhil) in immunology from Oxford University where he was a Rhodes Scholar. Turvey is a Fellow of the Royal College of Physicians and Surgeons of Canada and a Diplomate of the American Board of Pediatrics.
Turvey provides clinical care in the specialties of clinical immunology and rheumatology, while his research program focuses on pediatric infectious and inflammatory diseases. Specifically, Turvey is interested in the role of innate immunity in protecting infants and young children from infectious agents, and how abnormalities of the innate immune system contribute to inflammatory diseases of childhood.
University: University of British Columbia
Position: Aubrey J. Tingle Professor of Pediatric Immunology; Associate Professor, Department of Pediatrics
Research Location: Child & Family Research Institute
Ali S, Hirschfeld AF, Mayer ML, Fortuno ES, Corbett N, Schneiderman J, Fjell CD, Hsu K, Marr N, Yan J, Akhabir L, Aminuddin F, Lacaze-Masmonteil T, Hegele RG, Becker A, Chan-Yeung M, Hancock REW, Kollmann TR, Daley D, Sandford AJ, Lavoie PM, Turvey SE (2013). Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis and bronchopulmonary dysplasia. J Immunol (in press).
Blohmke CJ, Mayer ML, Fjell CD, Sze M, Tang A, Hirschfeld AF, Chilvers MA, Hogg JC, Falsafi R, Hancock REW, Turvey SE (2012). ER stress, the unfolded protein response and inflammation in lung disease of humans with cystic fibrosis. J Immunol 189(11):5467-75.
Turvey SE, Leo SH, Boos A, Deans GD, Prendiville J, Crawford RI, Senger C, Conley ME, Tilley P, Junker A, Janz L, Azana R, Hoang L, Morton TL (2012). Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia. J Clin Immunol 32(6):1404-8.
N. Marr, Turvey SE (2012). Role of human Toll-like receptor 4 in respiratory syncytial virus-induced nuclear factor-κB activation, viral entry and replication. Innate Immunity 18(6):856-65.
Blohmke CJ, Park J, Hirschfeld AF, Victor RE, Schneiderman J, Stefanowicz D, Chilvers MA, Durie PR, Corey M, Zielenski J, Dorfman R, Sandford AJ, Daley D, Turvey SE (2010). Toll-like receptor 5 is an anti-inflammatory target and modifier gene in cystic fibrosis. J Immunol 185(12):7731-8.